Funding Opportunity: N.C. Diabetes Research Center releases new RFA
The North Carolina Diabetes Research Center (NCDRC) has released an RFA for projects that have a clear diabetes focus.
The Pilot and Feasibility (P&F) program is designed to encourage and facilitate novel basic, clinical and translational research. Projects must demonstrate a clear path to subsequent grant support, translation to clinical programs, new company formation, licensing, not-for-profit partnering, or other channels. Collaborative projects with investigators from other NCDRC institutions will be given priority for funding, as will proposals that make meaningful use of one of the following Core facilities:
- Duke Metabolomics
- WF Proteomics/Genomics
- UNC Advanced Clinical Studies Methods
- WF Novel Animal Models
Letter of Intent Deadline: August 25, 2021, 11:59 p.m.
Full Application Deadline: October 20, 2021, 11:59 p.m.
Project Start Date: April 1, 2022
For additional information on this funding opportunity, please contact Brittney Jackson at This email address is being protected from spambots. You need JavaScript enabled to view it..
The goal of the NCDRC is to increase the impact of the already important diabetes research ongoing at Duke University, North Carolina Agricultural and Technical State University (N.C. A&T), the University of North Carolina at Chapel Hill (UNC), and Wake Forest School of Medicine (WF). Each has rich resources and outstanding investigators, and the NCDRC represents a timely opportunity to enhance interactions among these research communities and expand unique capabilities at each site to their neighboring campuses.
The mission of the NCDRC is to provide investigators, both established in or new to diabetes research, with access to powerful research technologies to enhance the impact of their work, as well as to connect investigators with collaborators, both at intra - and inter-institutional levels, to broaden the scope of their projects.
